SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ipca Laboratories gets VAI classification for Piparia manufacturing facility

24 Aug 2023 Evaluate

Ipca Laboratories’ Piparia (Silvassa) formulations manufacturing facility has received Voluntary Action Indicated (VAI) classification from U.S. Food and Drug Administration (USFDA). Based on this inspection, this facility is considered to be in a minimally acceptable state of compliance with regards to current good manufacturing practice (CGMP). 
USFDA had conducted inspection at the said manufacturing facility from April 18, 2023 to April 26, 2023, which inspection resulted into 3 observations under USFDA Form 483. 

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations.

Ipca Laboratories Share Price

1553.45 9.50 (0.62%)
06-May-2026 10:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1829.00
Dr. Reddys Lab 1287.50
Cipla 1344.65
Zydus Lifesciences 925.40
Lupin 2393.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×